Arcutis Biotherapeutics Inc (ARQT)
8.995
-0.12
(-1.37%)
USD |
NASDAQ |
May 17, 13:25
Arcutis Biotherapeutics Total Liabilities (Quarterly): 253.60M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 253.60M |
| December 31, 2023 | 252.70M |
| September 30, 2023 | 246.24M |
| June 30, 2023 | 240.18M |
| March 31, 2023 | 239.73M |
| December 31, 2022 | 239.69M |
| September 30, 2022 | 238.14M |
| June 30, 2022 | 105.08M |
| March 31, 2022 | 110.34M |
| December 31, 2021 | 110.48M |
| Date | Value |
|---|---|
| September 30, 2021 | 24.01M |
| June 30, 2021 | 18.40M |
| March 31, 2021 | 20.42M |
| December 31, 2020 | 27.65M |
| September 30, 2020 | 24.94M |
| June 30, 2020 | 23.05M |
| March 31, 2020 | 12.51M |
| December 31, 2019 | 172.04M |
| September 30, 2019 | 81.25M |
| December 31, 2018 | 75.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.51M
Minimum
Mar 2020
253.60M
Maximum
Mar 2024
128.44M
Average
110.34M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| AdaptHealth Corp | 3.033B |
| Pfizer Inc | 128.54B |
| Adverum Biotechnologies Inc | 85.54M |
| Apellis Pharmaceuticals Inc | 565.25M |
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 478.54M |
| Shareholders Equity (Quarterly) | 224.94M |
| Debt to Equity Ratio | 0.9016 |
| Current Ratio | 9.894 |
| Net Debt Paydown Yield | -0.09% |